InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.16
(
0.47%
)
US TECH 100
18,024.00
(
0.56%
)
Dow Jones
39,497.54
(
0.13%
)
Brent Oil
79.49
(
0.00%
)
Bitcoin
60,440.68
(
-0.72%
)

Replies to post #5483 on Lexington Biosciences Inc. (LXGTF)

Replies to #5483 on Lexington Biosciences Inc. (LXGTF)
icon url

Door2Door

12/18/17 5:55 PM

#5484 RE: StockBro75 #5483

And EndoPAT can't even compete on terms of cost point, convenience, even accuracy. LXGTF HeartSentry will dominate from the beginning of its clearance by FDA